Prednisolone: Clinical Trials

200 trials of Prednisolone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

89 completed, 31 unknown, 30 recruiting, 17 active not recruiting. 200 Phase 3, 31 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3200Completed 89, Unknown 31, Recruiting 30, Active not recruiting 17, Terminated 15, Withdrawn 9, Not yet recruiting 8, Suspended 1
Phase 231Completed 12, Unknown 8, Active not recruiting 3, Recruiting 3, Not yet recruiting 2, Terminated 2, Withdrawn 1

Follow Prednisolone: new trials by email Literature Review of Prednisolone trials Research Report on Prednisolone

Trials (filtered) newest first · largest first

All 200 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma
Phase 2 / Phase 3Not yet recruitingChildren's Oncology Group17082027-01-312026-11-20
A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel in Girls and Women With Female Genital Schistosomiasis
Praziquantel 80, Prednisolone, Diclofenac - Female Genital Schistosomiasis
Phase 3Not yet recruitingBrian Ngwira8002027-01-012026-11-04
ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.
Hydroxychloroquine (HCQ), No Hydroxychloroquine (HCQ), Prednisone or Prednisolone - Rheumatic Fever, Rheumatic Heart Disease in Children
Phase 3Not yet recruitingStarship Child Health, Te Toka Tumai Auckland6002026-12-012026-10-07
Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-Thalassemia
Thalidomide, Danazol, Prednisolone - Beta-Thalassemia, Thalassemia
Phase 3RecruitingKhyber Medical University Peshawar1722026-10-122026-10-21
A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]
Risvutatug rezetecan (Ris-Rez), Enzalutamide, Abiraterone - Neoplasms, Prostate
Phase 3RecruitingGlaxoSmithKline6842026-09-012026-10-02
Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome
Zuberitamab, standard corticosteroid treatment - Nephrotic Syndrome
Phase 3Not yet recruitingChildren's Hospital of Fudan University1202026-08-202026-08-14
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
MK-1045, Rituximab, Rituximab biosimilar - Follicular Lymphoma
Phase 2 / Phase 3RecruitingMerck Sharp & Dohme LLC9602026-06-222026-11-13
Colchicine for Autoimmune and Subacute Thyroiditis
colchicine, Prednisolone, NSAID - Hashimoto Thyroiditis, Subacute Thyroiditis
Phase 2 / Phase 3RecruitingMansoura University3002026-06-152026-07-29
"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis"
Prednisolone, Placebo - Hypersensitivity Pneumonitis
Phase 3Not yet recruitingAssistance Publique - Hôpitaux de Paris1202026-06-012025-10-07
PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis
N-Acetylcysteine (NAC) Treatment, Prednisolone, Placebo of N-acetylcysteine - Alcoholic Hepatitis
Phase 3RecruitingUniversity Hospital, Lille4772026-05-222026-06-01
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
BNT324, Docetaxel, Prednisone/prednisolone - Metastatic Castration-resistant Prostate Cancer
Phase 3RecruitingBioNTech SE7362026-04-222026-11-17
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Pasritamig, Docetaxel, Prednisone/Prednisolone - Prostatic Neoplasms, Castration-Resistant
Phase 3RecruitingJanssen Research & Development, LLC8002025-12-192026-11-03
REmission in Membranous Nephropathy International Trial (REMIT)
Obinutuzumab, Oral prednisolone and cyclophosphamide - Primary Membranous Nephropathy
Phase 3WithdrawnThe University of Queensland2025-10-312025-11-28
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Saruparib, Placebo, Abiraterone + Prednisolone/Prednisone - Prostate Cancer
Phase 3RecruitingAstraZeneca7002025-08-062026-10-14
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
Golcadomide, Rituximab, Lenalidomide - Follicular Lymphoma
Phase 3RecruitingCelgene4002025-07-282026-05-20
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Ifinatamab deruxtecan, Docetaxel, Prednisone - Prostate Cancer, Prostatic Neoplasms
Phase 3RecruitingMerck Sharp & Dohme LLC14402025-05-132026-10-30
Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases
Bevacizumab, Placebo, Prednisolone - Radionecrosis of Brain, Brain Metastases
Phase 3RecruitingInstitut Cancerologie de l'Ouest842025-04-292025-08-17
Short Course Steroids in Alcohol Associated Hepatitis
Prednisolone 40 mg - Alcoholic Hepatitis
Phase 3CompletedAsian Institute of Gastroenterology, India1512025-04-072026-09-01
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
BMS-986365, Enzalutamide, Abiraterone - Metastatic Castration-resistant Prostate Cancer
Phase 3Active not recruitingCelgene9602025-03-132026-09-30
Rituximab in the First Episode of Paediatric Nephrotic Syndrome
Rituximab, Corticosteroid - Steroid-Sensitive Nephrotic Syndrome
Phase 3Not yet recruitingChildren's Hospital of Fudan University1382025-03-012025-01-22

Showing 20 of 200. Sign in to see all of them.

Conditions studied

Lymphoma (15)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (13)  ·  Prostatic Neoplasms (13)  ·  Leukemia (9)  ·  Lymphoma, Follicular (9)  ·  Lymphoma, Large B-Cell, Diffuse (9)  ·  Asthma (8)  ·  Lymphoma, Non-Hodgkin (7)  ·  Burkitt Lymphoma (5)  ·  Hepatitis, Alcoholic (5)  ·  Nephrotic Syndrome (5)  ·  Arthritis, Rheumatoid (4)  ·  Aspergillosis, Allergic Bronchopulmonary (4)  ·  Glomerulonephritis, IGA (4)  ·  Hodgkin Disease (4)

Sponsors

Sanofi (8)  ·  GlaxoSmithKline (6)  ·  Merck Sharp & Dohme LLC (6)  ·  Hoffmann-La Roche (5)  ·  Children's Hospital of Fudan University (4)  ·  Children's Oncology Group (4)  ·  EMS (4)  ·  Medical Research Council (4)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  European Organisation for Research and Treatment of Cancer - EORTC (3)  ·  National Cancer Institute (NCI) (3)  ·  The Hospital for Sick Children (3)  ·  Ain Shams University (2)  ·  All India Institute of Medical Sciences (2)

Countries

United Kingdom (54)  ·  United States (52)  ·  Germany (50)  ·  France (45)  ·  Canada (41)  ·  Australia (40)  ·  Italy (37)  ·  Spain (34)  ·  China (32)  ·  Brazil (30)  ·  Netherlands (30)  ·  Poland (29)  ·  Belgium (28)  ·  South Korea (24)  ·  Japan (22)

Top investigators

Birgit Burkhardt, Prof. Dr. Dr. (2)  ·  Daniel TM Chan, Prof (2)  ·  Jack F Wetzels, MD, PhD (2)  ·  Juergen Braun, MD (2)  ·  Qian Shen (2)  ·  Satinder Aneja, MD (2)  ·  A. van Rhenen, MD (1)

Results publications

PMID 34778952, PMID 35224732, PMID 37505794, PMID 38299639, PMID 41671463, PMID 10820362, PMID 12111109, PMID 12153596, PMID 12239143, PMID 12694250, PMID 12780755, PMID 15353542, PMID 15637138, PMID 15801953, PMID 15952999, PMID 16314615, PMID 17039234, PMID 17132719, PMID 17138821, PMID 17407135, PMID 17475943, PMID 17611565, PMID 17658394, PMID 17658395, PMID 18071116, PMID 18371107, PMID 18493992, PMID 18567886, PMID 18675464, PMID 18990168, PMID 19016733, PMID 19020548, PMID 19132729, PMID 19192962, PMID 19212338, PMID 19228428, PMID 19657114, PMID 19666912, PMID 19731319, PMID 19773418, PMID 19895612, PMID 20007809, PMID 20378563, PMID 20407035, PMID 20459775, PMID 20511662, PMID 20592248, PMID 21106984, PMID 21483000, PMID 21496005

NIH funding

U10CA180886 (6), 2017 (5), 2023 (5), 2025 (4), 2009 (3), 2015 (3), 2014 (2), 2016 (2), 2018 (2), 2004 (1), 2005 (1), 2008 (1), P01CA068484 (1), P30CA006516 (1), P30CA036727 (1)